Cervical cancer detection kit taking p16 and MCM2 as targets and interpretation method thereof
The invention belongs to the technical field of in-vitro diagnosis medical instruments, and particularly discloses a cervical cancer detection kit taking p16 and MCM2 as targets, which comprises a p16/MCM2 primary antibody working mixed solution, a goat anti-mouse/rabbit secondary antibody working m...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YAO YUANTING LI KEQIANG XU ZHOU GU ZHONGJIAN |
| description | The invention belongs to the technical field of in-vitro diagnosis medical instruments, and particularly discloses a cervical cancer detection kit taking p16 and MCM2 as targets, which comprises a p16/MCM2 primary antibody working mixed solution, a goat anti-mouse/rabbit secondary antibody working mixed solution, a DAB working mixed solution, an RED working mixed solution and hematoxylin. The invention also discloses an interpretation method of the detection kit, the cervical cancer detection kit and the interpretation method thereof provided by the invention are adopted to carry out cervical cancer and precancerous lesion risk assessment, so that III-level risk assessment can be accurately carried out, and corresponding three-layer risk management can be accurately given; the method can be simultaneously applied to accurate preliminary screening and accurate shunting, is high in sensitivity and accuracy, increases a positive predicted value, and is an accurate screening method.
本发明属于体外诊断医疗器械技术领域，具体公开了一种以p16和 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN114152749A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN114152749A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN114152749A3</originalsourceid><addsrcrecordid>eNqNi0EKwjAUBbNxIeodvgdwkVotLiUoburKteWTvrahNQnJx_MrxQO4GhhmluppkN7O8kSWvUWiFgIrLnganZDw6HxPUR-JfUu1qQvi_NWph-TZOS9IMUF4vl6QIbQkAxJCt1aLjqeMzY8rtb1eHua2QwwNcmQLD2nMXetSH4qqPJ33_zQflbU7gw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cervical cancer detection kit taking p16 and MCM2 as targets and interpretation method thereof</title><source>esp@cenet</source><creator>YAO YUANTING ; LI KEQIANG ; XU ZHOU ; GU ZHONGJIAN</creator><creatorcontrib>YAO YUANTING ; LI KEQIANG ; XU ZHOU ; GU ZHONGJIAN</creatorcontrib><description>The invention belongs to the technical field of in-vitro diagnosis medical instruments, and particularly discloses a cervical cancer detection kit taking p16 and MCM2 as targets, which comprises a p16/MCM2 primary antibody working mixed solution, a goat anti-mouse/rabbit secondary antibody working mixed solution, a DAB working mixed solution, an RED working mixed solution and hematoxylin. The invention also discloses an interpretation method of the detection kit, the cervical cancer detection kit and the interpretation method thereof provided by the invention are adopted to carry out cervical cancer and precancerous lesion risk assessment, so that III-level risk assessment can be accurately carried out, and corresponding three-layer risk management can be accurately given; the method can be simultaneously applied to accurate preliminary screening and accurate shunting, is high in sensitivity and accuracy, increases a positive predicted value, and is an accurate screening method.
本发明属于体外诊断医疗器械技术领域，具体公开了一种以p16和</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220308&DB=EPODOC&CC=CN&NR=114152749A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220308&DB=EPODOC&CC=CN&NR=114152749A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAO YUANTING</creatorcontrib><creatorcontrib>LI KEQIANG</creatorcontrib><creatorcontrib>XU ZHOU</creatorcontrib><creatorcontrib>GU ZHONGJIAN</creatorcontrib><title>Cervical cancer detection kit taking p16 and MCM2 as targets and interpretation method thereof</title><description>The invention belongs to the technical field of in-vitro diagnosis medical instruments, and particularly discloses a cervical cancer detection kit taking p16 and MCM2 as targets, which comprises a p16/MCM2 primary antibody working mixed solution, a goat anti-mouse/rabbit secondary antibody working mixed solution, a DAB working mixed solution, an RED working mixed solution and hematoxylin. The invention also discloses an interpretation method of the detection kit, the cervical cancer detection kit and the interpretation method thereof provided by the invention are adopted to carry out cervical cancer and precancerous lesion risk assessment, so that III-level risk assessment can be accurately carried out, and corresponding three-layer risk management can be accurately given; the method can be simultaneously applied to accurate preliminary screening and accurate shunting, is high in sensitivity and accuracy, increases a positive predicted value, and is an accurate screening method.
本发明属于体外诊断医疗器械技术领域，具体公开了一种以p16和</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAUBbNxIeodvgdwkVotLiUoburKteWTvrahNQnJx_MrxQO4GhhmluppkN7O8kSWvUWiFgIrLnganZDw6HxPUR-JfUu1qQvi_NWph-TZOS9IMUF4vl6QIbQkAxJCt1aLjqeMzY8rtb1eHua2QwwNcmQLD2nMXetSH4qqPJ33_zQflbU7gw</recordid><startdate>20220308</startdate><enddate>20220308</enddate><creator>YAO YUANTING</creator><creator>LI KEQIANG</creator><creator>XU ZHOU</creator><creator>GU ZHONGJIAN</creator><scope>EVB</scope></search><sort><creationdate>20220308</creationdate><title>Cervical cancer detection kit taking p16 and MCM2 as targets and interpretation method thereof</title><author>YAO YUANTING ; LI KEQIANG ; XU ZHOU ; GU ZHONGJIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN114152749A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>YAO YUANTING</creatorcontrib><creatorcontrib>LI KEQIANG</creatorcontrib><creatorcontrib>XU ZHOU</creatorcontrib><creatorcontrib>GU ZHONGJIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAO YUANTING</au><au>LI KEQIANG</au><au>XU ZHOU</au><au>GU ZHONGJIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cervical cancer detection kit taking p16 and MCM2 as targets and interpretation method thereof</title><date>2022-03-08</date><risdate>2022</risdate><abstract>The invention belongs to the technical field of in-vitro diagnosis medical instruments, and particularly discloses a cervical cancer detection kit taking p16 and MCM2 as targets, which comprises a p16/MCM2 primary antibody working mixed solution, a goat anti-mouse/rabbit secondary antibody working mixed solution, a DAB working mixed solution, an RED working mixed solution and hematoxylin. The invention also discloses an interpretation method of the detection kit, the cervical cancer detection kit and the interpretation method thereof provided by the invention are adopted to carry out cervical cancer and precancerous lesion risk assessment, so that III-level risk assessment can be accurately carried out, and corresponding three-layer risk management can be accurately given; the method can be simultaneously applied to accurate preliminary screening and accurate shunting, is high in sensitivity and accuracy, increases a positive predicted value, and is an accurate screening method.
本发明属于体外诊断医疗器械技术领域，具体公开了一种以p16和</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN114152749A |
| source | esp@cenet |
| subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
| title | Cervical cancer detection kit taking p16 and MCM2 as targets and interpretation method thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T05%3A58%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAO%20YUANTING&rft.date=2022-03-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN114152749A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |